Literature DB >> 7614422

Elevated endothelin-1 plasma concentration in patients with essential hypertension.

A Januszewicz1, M Lapiński, B Symonides, E Dabrowska, A Kuch-Wocial, E Trzepla, H Ignatowska-Switalska, B Wocial, J Chodakowska, W Januszewicz.   

Abstract

BACKGROUND: Endothelin-1 (ET-1) may play an important role in the development and maintenance of hypertensive states. In patients with essential hypertension, ET-1 plasma concentration increases or remains unchanged. The aim of the present study was to investigate ET-1 plasma concentration in patients with mild-to-moderate essential hypertension and its interrelationship with catecholamines, neuropeptide Y and atrial natriuretic peptide (ANP).
METHODS: The study included 37 patients (mean age 38.2 +/- 1.6 years) with mild-to-moderate essential hypertension. The control group consisted of 21 healthy volunteers (mean age 35.6 +/- 1.4 years). ET-1, neuropeptide Y and ANP were determined by radioimmunoassay methods and catecholamine plasma concentration was determined radioenzymatically.
RESULTS: Our study shows that plasma ET-1 and neuropeptide Y levels are elevated in patients with essential hypertension compared with a control group. No correlation was found in either of the groups between plasma ET-1 level and plasma neuropeptide Y, catecholamine or ANP concentrations.
CONCLUSION: Our results suggest that ET-1 is relevant in the development and maintenance of elevated blood pressure.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7614422

Source DB:  PubMed          Journal:  J Cardiovasc Risk        ISSN: 1350-6277


  7 in total

1.  Higher circulatory level of endothelin-1 in hypertensive subjects screened through a cross-sectional study of rural Bangladeshi women.

Authors:  Shamima Akter; Subrina Jesmin; Yoshio Iwashima; Sakuramoto Hideaki; Md Arifur Rahman; Md Majedul Islam; Masao Moroi; Nobutake Shimojo; Naoto Yamaguchi; Takashi Miyauchi; Satoru Kawano; Taro Mizutani; Yuhei Kawano
Journal:  Hypertens Res       Date:  2014-11-13       Impact factor: 3.872

Review 2.  Physiology of endothelin and the kidney.

Authors:  Donald E Kohan; Edward W Inscho; Donald Wesson; David M Pollock
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

Review 3.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

Review 4.  Endothelin and its antagonists in hypertension: can we foresee the future?

Authors:  P Moreau; T J Rabelink
Journal:  Curr Hypertens Rep       Date:  1999 Feb-Mar       Impact factor: 5.369

5.  Neuro-endocrine regulation of blood pressure.

Authors:  Sandeep Chopra; Chris Baby; Jubbin Jagan Jacob
Journal:  Indian J Endocrinol Metab       Date:  2011-10

6.  Circulating Levels of Endothelin-1 and Big Endothelin-1 in Patients with Essential Hypertension.

Authors:  Krasimir Kostov; Alexander Blazhev
Journal:  Pathophysiology       Date:  2021-10-25

7.  Endothelins and markers of renal damage in recently diagnosed hypertensive patients.

Authors:  Antonia Maldonado-Martín; Dolores Rueda-Illescas; Blas Gil-Extremera; Leticia Soriano-Carrascosa; Trinidad Alonso-Morales; Francisco García-Pérez; José García-Chicano; Juan de Dios Luna del Castillo
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Sep-Oct       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.